Read more
Maria THEMELI is a graduate of the University of Patras holding a degree (2006) and a PhD (2010) from the Faculty of Medicine.
She is an Assistant Professor of Medicine at VU University Medical Center in the Netherlands and a researcher who has been recognised as a very important contributor to the treatment of hematological cancer.
Her postdoctoral research work at the Memorial Sloan Kettering Cancer Center in New York led to high-impact discoveries in the field of immunotherapy with CAR-T cells, which feature an anticancer activity. This method has even been patented. The goal of the researcher is to make it accessible to everyone, because, as she believes, cancer treatment cannot be a privilege of just a few people. [More: https://impactalk.gr/en/stories-talk/maria-themeli-persistent-visionary-life]
More:
https://www.linkedin.com/in/maria-themeli-a04a1a92/?originalSubdomain=nl
Maria THEMELI is a graduate of the University of Patras holding a degree (2006) and a PhD (2010) from the Faculty of Medicine.
She is an Assistant Professor of Medicine at VU University Medical Center in the Netherlands and a researcher who has been recognised as a very important contributor to the treatment of hematological cancer.
Her postdoctoral research work at the Memorial Sloan Kettering Cancer Center in New York led to high-impact discoveries in the field of immunotherapy with CAR-T cells, which feature an anticancer activity. This method has even been patented. The goal of the researcher is to make it accessible to everyone, because, as she believes, cancer treatment cannot be a privilege of just a few people. [More: https://impactalk.gr/en/stories-talk/maria-themeli-persistent-visionary-life]
More:
https://www.linkedin.com/in/maria-themeli-a04a1a92/?originalSubdomain=nl